MiR-122 was found to be elevated in the advanced MF stages, and its overexpression lowered the susceptibility to chemotherapy-induced apoptosis through a signaling circuit involving Akt activation and p53 suppression in CTCL cells [90]. Here, AKT1 is linked to mycosis fungoides.